Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lu AA24530 dose-finding study in major depressive disorder
2007-001071-11Phase 2Completed
- Sponsor
- Lundbeck
- Start
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vortioxetine in major depressive disorder (MDD), sponsored by Lundbeck. Started Jul 2007; status: completed.
02
Drugs
vortioxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2007-001071-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001071-11.